Pfizer BionTech vaccine, at the start a global study to test the Covid-19 vaccine in children aged 6 months to eleven. This was announced by the two pharmaceutical companies. “We are proud to initiate this much-needed study for children and families who are eagerly awaiting a possible vaccine,” Pfizer CEO Albert Bourla said in a tweet.
“As a father and scientist – he adds – I would like to thank our participants, their parents and those who care for them, for wanting to study. We must continue to collect evidence on the safety and efficacy of vaccines against Covid-19 to important populations such as children “.